Fig. 1: LTSs of PDAC develop tumours with distinct recurrence time, multiplicity and tissue tropism.
From: Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
a, The experimental design. b, c, Overall survival (b) and disease-free survival (c) of patients with PDAC. d–g, The number (d), correlation with overall survival (e), patterns (f) and sites (g) of recurrent PDACs. In g, other indicates omentum, aorta, diaphragm and perirectum (STS); and pericardium, inferior vena cava, adrenal, kidney and liver (LTS). n indicates the number of individual patients (b–f) or recurrent tumours (g). The horizontal bars show the median values. P values were determined using two-tailed log-rank tests (Mantel–Cox; b and c), two-tailed Mann–Whitney U-tests (d), two-tailed Pearson correlation (e) and two-tailed χ2 tests (f).
